Lifeboat Foundation

A new method for imaging tattoos reveals intricate designs on Chancay mummies from Peru.

A $7 billion all-electric light rail project is underway in the Capital City. The Austin Light Rail now has a team in place to build the city’s first light rail system, set to shakeup the city’s public transportation in the near future.

Last month, the Austin Transit Partnership selected AECOM, a Dallas-based infrastructure consulting firm, to bring the first phase of the approximately 10-mile light rail to life in Austin, according to a release. Now AECOM is preparing to offer more updates to public on the project’s progress as the organization continues to implement the plan.

In an astronomical feat, using NASA

NASA, the National Aeronautics and Space Administration, is the United States government agency responsible for the nation’s civilian space program and for aeronautics and aerospace research. Established in 1958 by the National Aeronautics and Space Act, NASA has led the U.S. in space exploration efforts, including the Apollo moon-landing missions, the Skylab space station, and the Space Shuttle program.

Let’s see what they’ve got.

TSMC is aiming to begin mass production of Apple’s A-series chips for the iPhone as soon as this quarter at its Arizona plant.

Astrophysical bow shocks and other multiscale phenomena work like cosmic particle accelerators to launch electrons to near-light speeds.

New research by a team of Indiana University School of Medicine scientists and their collaborators has uncovered a novel vulnerability in prostate cancer animal models that starves prostate tumors of critical nutrients and stunts their growth, which could lead to the development of new treatments for the deadly disease.

Led by IU School of Medicine’s Kirk Staschke, Ph.D., assistant research professor of biochemistry and molecular biology, and Ronald C. Wek, Ph.D., Showalter Professor of Biochemistry, the study was recently published in Science Signaling.

Prostate cancer is a leading cause of cancer deaths in American men. Current treatments target the hormone testosterone, which prostate cancer cells need to grow. Unfortunately, prostate tumors frequently become resistant to these treatments, leaving doctors with few options to stop the disease.

Link :

Genes are mapping the way to cancer cures.

By the end of 2024, artificial intelligence (AI) and machine learning (ML) had established themselves as the main transformative forces behind recent technological advancements in healthcare. A report by Silicon Valley Bank states that in 2024, the amount of VC investment in health AI in the U.S. was expected to reach $11.1 billion, the highest number since 2021.

In my experience, the main driver behind the AI investment and adoption craze is the measurable value technology offers healthcare providers. A 2023 National Bureau of Economic Research study indicates that integrating AI can save the U.S. healthcare system up to $360 billion annually. A 2023 survey by the AMA shows that physicians see AI as a way to reduce the administrative burden of documentation (54%) and improve workflow efficiency (69%).

But do these positive changes reflect on the quality of care, and do patients benefit from AI and ML-powered solutions? In this article, I share my take on the transformative potential of AI and ML in the modern care delivery process.